Analysis underway with a view to increasing (removing/reducing bottlenecks) production capacity by 20-25%.....
Coupled with yet to be contracted capacity, higher spot rates and 100% ownership of receipts....
...this is exactly what I wanted to hear.
- Forums
- ASX - By Stock
- Ann: 2Q FY24 Quarterly Report & Appendix 5B
Analysis underway with a view to increasing (removing/reducing...
-
- There are more pages in this discussion • 345 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add STX (ASX) to my watchlist
(20min delay)
|
|||||
Last
19.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $558.7M |
Open | High | Low | Value | Volume |
19.5¢ | 20.0¢ | 19.0¢ | $1.491M | 7.689M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
29 | 2173603 | 19.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
19.5¢ | 23539 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
29 | 2173603 | 0.190 |
21 | 1333518 | 0.185 |
35 | 1703517 | 0.180 |
15 | 1335514 | 0.175 |
38 | 3717087 | 0.170 |
Price($) | Vol. | No. |
---|---|---|
0.195 | 23539 | 1 |
0.200 | 487234 | 9 |
0.205 | 480375 | 8 |
0.210 | 642110 | 7 |
0.215 | 464022 | 10 |
Last trade - 16.10pm 24/09/2024 (20 minute delay) ? |
Featured News
STX (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, Managing Director and CEO
Steven Gourlay
Managing Director and CEO
SPONSORED BY The Market Online